InterVene Inc. is involved in addressing Chronic Venous Insufficiency (CVI), providing treatment options that include lifestyle modifications, compression therapy, and medications, with a focus on managing chronic venous flow obstruction and its complications.

InterVene Inc.

InterVene, Inc. | 1,341 followers on LinkedIn. Developing interventional technologies to treat and prevent severe, complex venous diseases | InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases.
 
The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use.

Abha Chinubhai

President, Sonoma Medical Consultants

Mel Schatz

Co-Founder/CEO, Throne: Revolutionizing public bathrooms

Fletcher Wilson

Abraham A Van Scoit

InterVene, Inc.

InterVene, Inc. is excited to join a select group of medical device companies presenting innovative technologies at #TheVEINS24 Innovation Summit in Las Vegas this Sunday (11/3/2024). Kush Desai , MD will present InterVene's #Recana (formerly Chronus) system, currently in development for recanalizing chronic and postthrombotic (PT) venous occlusion and obstruction. Recana's design facilitates treatment in cases of chronic in-stent restenosis (ISR) and late percutaneous mechanical thrombectomy (PMT) for chronic tissue and obstructed and occluded venous stents. Dr. Desai takes the stage from 7:22-7:33 am during the Blue Sky Breakfast. Hope to see you there! #VIVA24 #chronicvenousinsufficiency #CVI #deepvenousstenting #deepveinthrombosis #DVT Jeff Elkins Catherine Matthes Jay Schmelter Andrew Kleiboeker

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Nov 7, 2024 3:44 AM	ac7951ed
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general	Nov 7, 2024 3:44 AM	21a4656a
news processing advanced	general
crunchbase trigger	general	Nov 7, 2024 3:44 AM	e6768474
crunchbase profile	general
li profile	general	Nov 7, 2024 3:44 AM	3048c9c3
translate crunchbase fundingrounds	general
peers	general	Nov 7, 2024 3:44 AM	d7193cec
news basic	general	Nov 7, 2024 3:44 AM	b1ad78be
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis	Nov 7, 2024 3:44 AM	4aafef1c
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

INTE

COM:INTERVENE-MED

InterVene Inc.